2016 will be profitable with the 1.6 million carbon credit and surge in business due to JASON bankruptcy. The last time ARCI was profitable it was $3.
MEIP has an AML wonder drug.
The final results of the AML trial will show AT LEAST 16 MONTH progression free survival for AML patients.
Thats twice as good as the currently approved treatment.
SNSS has a $500 million market cap for an AML drug with nowhere near the results.
Please explain your assertion that the Company needs capital when the CEO said they already have an ATM in place, the CEO said they don't need the ATM, and they have plenty of cash.
Beaccurate I respect your DD.
But in this market every small cap getting killed.
What gives you the confidence SMSI can do well in this environment?
A speculative buy. Of course they won't break even this year.
If they were profitable this would be a $20 stock.
I haven't followed this company as closely as I should have. Went back to Jan 11 presentation but thats not clear.
What study is OXGN conducting that will provide GOG data and what are the expected timelines?
Very rare for a lender to provide 25 million in funding to a biotech company. They must have been very confident in business plan.
This company was trading at a price of 18 cents ($2.70) pre split. Low float stocks got hit the hardest in market crash but also will bounce back the fastest in the rebound.
This is the type of company that could get back to $3 in one day because of the low float and sex appeal.
Could you clarify if there was anything specific in IBD article supporting that statement?
I have 500000 shares bought at .45 I wished I had sold.
This an awful market and MCZ didn't deliver. That simple.
No use sugar coating it Today's pr was awful
SCON is the next PLUG imo